Sort
25,944 grants matching “neurodegeneration”
Assessing cellular aging in old and rejuvenated neurons from Alzheimer patients
$1,169,591Fred H Gage · Salk Institute For Biological Studies · RF1 · FY2022 · AG
Behavioral and Neural Plasticity in the Aged
$1,169,211University Of California Irvine · P01 · FY2005 · AG
Cell Models for AD: Lipids and Related Signaling Pathways
$1,169,102Grace Y Sun · University Of Missouri-Columbia · P01 · FY2011 · AG
Lead optimization and development of novel targeted small molecule therapeutics for Alzheimers disease
$1,169,102Satheesh B Ravula · Epigen Biosciences, Inc. · R44 · FY2019 · AG
A Diagnostic Test for Dementia with Lewy Bodies
$1,168,467Todd Levine · Cnd Life Sciences, Inc. · R44 · FY2023 · AG
Genetic etiology of Amyotrophic Lateral Sclerosis
$1,168,456Bryan Traynor · National Institute On Aging · ZIA · FY2019 · AG
Axonal transport regulates synaptic function and axonal homeostasis
$1,168,166Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
TDP-43 Proteinopathies in ALS-Dementia
$1,166,835Virginia M Lee · University Of Pennsylvania · P01 · FY2011 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD
$1,166,648Jessica Elaine Young · University Of Washington · R01 · FY2025 · AG
Regulation Of Intracellular Iron Metabolism
$1,166,167Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Trajectories and Markers of Neurodegeneration in Carriers of the Fragile X Premutation
$1,165,703David R Hessl · University Of California At Davis · R01 · FY2025 · NS
Boston University Alzheimer's Disease Core Center
$1,165,637Neil W. Kowall · Boston University Medical Campus · P30 · FY2006 · AG
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding
$1,165,318Afonso C Silva · University Of Pittsburgh At Pittsburgh · R24 · FY2021 · AG
Molecular Genetics Of Scrapie Pathogenesis
$1,164,826Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
DEGENERATIVE AND DEMENTING DISEASES OF AGING
$1,164,349University Of California San Francisco · P01 · FY2001 · AG
Biomarkers of Catecholaminergic Neurodegeneration
$1,164,021David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
$1,164,000Dimitri Krainc · Northwestern University At Chicago · R35 · FY2024 · NS
Boston University Alzheimer's Disease Core Center
$1,163,677Neil W. Kowall · Boston University Medical Campus · P30 · FY2007 · AG
Validation of HYPE as an Actionable Target for Alzheimer's Disease
$1,162,500Kavita Shah · Purdue University · RF1 · FY2022 · NS
La Spada Outstanding Investigator Award
$1,162,302Albert R La Spada · University Of California-Irvine · R35 · FY2022 · NS
La Spada Outstanding Investigator Award
$1,162,302Albert R La Spada · University Of California-Irvine · R35 · FY2023 · NS
La Spada Outstanding Investigator Award
$1,162,302Albert R La Spada · University Of California-Irvine · R35 · FY2025 · NS
Canagliflozin as a Neuroprotective Agent to Improve Neuroinflammation and Cognitive Function during Aging
$1,161,852Marianna Sadagurski · Wayne State University · RF1 · FY2023 · AG
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury (CAPCOG-TBI)
$1,161,635Kan Ding · Ut Southwestern Medical Center · R01 · FY2025 · NS
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$1,161,033Craig C Weinkauf · University Of Arizona · R01 · FY2023 · AG